XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED RESULTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net sales $ 1,679 $ 1,743 $ 5,002 $ 5,464
Revenue, Product and Service [Extensible Enumeration] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Cost of goods sold $ (1,464) $ (1,379) $ (4,165) $ (4,199)
Gross profit 215 364 837 1,265
Selling and administrative expense (103) (134) (337) (424)
Research, development and engineering expense (20) (24) (62) (66)
Interest expense, net (87) (78) (252) (263)
Equity earnings 20 40 75 100
Other expense, net (82) (86) (98) (106)
Earnings (loss) before income taxes (57) 82 163 506
Provision for income taxes (19) (26) (102) (127)
Net earnings (loss) (76) 56 61 379
Net earnings attributable to non-controlling interests (4) (5) (13) (12)
Net earnings (loss) attributable to the Company $ (80) $ 51 $ 48 $ 367
Basic earnings per share:        
Net earnings (loss) attributable to the Company (in dollars per share) $ (0.52) $ 0.33 $ 0.31 $ 2.37
Weighted average shares outstanding (thousands) (in shares) 154,619 154,702 154,724 154,796
Diluted earnings per share:        
Net earnings (loss) attributable to the Company (in dollars per share) $ (0.52) $ 0.32 $ 0.31 $ 2.31
Weighted average diluted shares outstanding (thousands) (in shares) 154,619 159,285 157,537 159,236